Pharmaceutical Business review

PhotoMedex obtains FDA approval for Xtrac Velocity Laser

The Xtrac Velocity laser system is claimed to deliver the highest ultraviolet (UV) power of any medical excimer laser on the market today, while retaining all the reliability and clinical efficacy of its predecessor, the Xtrac Ultra. As a result, the Velocity is up to three times faster per treatment, creating a viable alternative to many of the current and costly psoriasis therapies, including therapies involving biologics, systemics and a combination of psoralen and UVA light (PUVA), but without any of the potential systemic side effects.

Jeff O’Donnell, president and CEO of PhotoMedex, said: John Koo has already reported on the effectiveness of the Xtrac Ultra in treating moderate to severe psoriasis, and given the widespread coverage already in place for treatment by the Xtrac laser for mild to moderate psoriasis and the Blue Cross national reference policy for severe psoriasis of less than 20% body area, we anticipate that coverage for such people suffering from moderate to severe psoriasis will increase.